These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26085406)

  • 21. Chiral one- and two-dimensional silver(I)-biotin coordination polymers.
    Altaf M; Stoeckli-Evans H
    Acta Crystallogr C; 2013 Feb; 69(Pt 2):127-37. PubMed ID: 23377677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vanadium complexes having [V(IV)O](2+) and [V(V)O(2)](+) cores with binucleating dibasic tetradentate ligands: Synthesis, characterization, catalytic and antiamoebic activities.
    Maurya MR; Khan AA; Azam A; Ranjan S; Mondal N; Kumar A; Avecilla F; Pessoa JC
    Dalton Trans; 2010 Feb; 39(5):1345-60. PubMed ID: 20104362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vanadium complexes having [VO]2+, [VO]3+ and [VO2]+ cores with hydrazones of 2,6-diformyl-4-methylphenol: synthesis, characterization, reactivity, and catalytic potential.
    Maurya MR; Haldar C; Kumar A; Kuznetsov ML; Avecilla F; Costa Pessoa J
    Dalton Trans; 2013 Sep; 42(33):11941-62. PubMed ID: 23680862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formation, preservation, and cleavage of the disulfide bond by vanadium.
    Wang D; Behrens A; Farahbakhsh M; Gätjens J; Rehder D
    Chemistry; 2003 Apr; 9(8):1805-13. PubMed ID: 12698438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elucidation of Binding Site and Chiral Specificity of Oxidovanadium Drugs with Lysozyme through Theoretical Calculations.
    Sciortino G; Sanna D; Ugone V; Micera G; Lledós A; Maréchal JD; Garribba E
    Inorg Chem; 2017 Nov; 56(21):12938-12951. PubMed ID: 28985059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Model investigations for vanadium-protein interactions: vanadium(III) compounds with dipeptides and their oxovanadium(IV) analogues.
    Tasiopoulos AJ; Tolis EJ; Tsangaris JM; Evangelou A; Woollins D; Slawin AM; Pessoa C; Correia I; Kabanos TA
    J Biol Inorg Chem; 2002 Apr; 7(4-5):363-74. PubMed ID: 11941494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new three-dimensional CdII supramolecular framework constructed from the 1-[(1H-tetrazol-5-yl)methyl]-1,4-diazoniabicyclo[2.2.2]octane ligand.
    Li Q; Wang HT; Zhou L
    Acta Crystallogr C Struct Chem; 2015 Feb; 71(Pt 2):93-6. PubMed ID: 25652273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aminoacid-derivatised picolinato-oxidovanadium(IV) complexes: characterisation, speciation and ex vivo insulin-mimetic potential.
    Esbak H; Enyedy EA; Kiss T; Yoshikawa Y; Sakurai H; Garribba E; Rehder D
    J Inorg Biochem; 2009 Apr; 103(4):590-600. PubMed ID: 19121544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring the effect of hydroxylic and non-hydroxylic solvents on the reaction of [V
    Biswas N; Patra D; Mondal B; Bera S; Acharyya S; Biswas AK; Mukhopadhyay TK; Pal A; Drew MGB; Ghosh T
    Dalton Trans; 2017 Aug; 46(33):10963-10985. PubMed ID: 28766668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supramolecular hydrogen-bonding patterns in salts of the antifolate drugs trimethoprim and pyrimethamine.
    Swinton Darious R; Thomas Muthiah P; Perdih F
    Acta Crystallogr C Struct Chem; 2018 Apr; 74(Pt 4):487-503. PubMed ID: 29620034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, characterization, and reactivity of mononuclear O,N-chelated vanadium(IV) and -(III) complexes of methyl 2-Aminocyclopent-1-ene-1-dithiocarboxylate based ligand: reporting an example of conformational isomerism in the solid state.
    Bhattacharyya S; Mukhopadhyay S; Samanta S; Weakley TJ; Chaudhury M
    Inorg Chem; 2002 May; 41(9):2433-40. PubMed ID: 11978110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidovanadium(IV) Schiff base complex derived from vitamin B6: synthesis, characterization, and insulin enhancing properties.
    Mukherjee T; Costa Pessoa J; Kumar A; Sarkar AR
    Inorg Chem; 2011 May; 50(10):4349-61. PubMed ID: 21495653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Supramolecular structural variations with changes in anion and solvent in silver(I) complexes of a semirigid, bitopic tris(pyrazolyl)methane ligand.
    Reger DL; Semeniuc RF; Rassolov V; Smith MD
    Inorg Chem; 2004 Jan; 43(2):537-54. PubMed ID: 14731015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. o-Iminobenzosemiquinonate and o-imino-p-methylbenzosemiquinonate anion radicals coupled VO2+ stabilization.
    Roy AS; Saha P; Adhikary ND; Ghosh P
    Inorg Chem; 2011 Mar; 50(6):2488-500. PubMed ID: 21348449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of phosphate on the nuclease activity of vanadium compounds.
    Butenko N; Pinheiro JP; Da Silva JP; Tomaz AI; Correia I; Ribeiro V; Costa Pessoa J; Cavaco I
    J Inorg Biochem; 2015 Jun; 147():165-76. PubMed ID: 25958839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assemblies of salen-type oxidovanadium(IV) complexes: substituent effects and in vitro protein tyrosine phosphatase inhibition.
    Zabierowski P; Szklarzewicz J; Gryboś R; Modryl B; Nitek W
    Dalton Trans; 2014 Dec; 43(45):17044-53. PubMed ID: 25303031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural diversity in manganese, iron and cobalt complexes of the ditopic 1,2-bis(2,2'-bipyridyl-6-yl)ethyne ligand and observation of epoxidation and catalase activity of manganese compounds.
    Madhu V; Ekambaram B; Shimon LJ; Diskin Y; Leitus G; Neumann R
    Dalton Trans; 2010 Aug; 39(31):7266-75. PubMed ID: 20582360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of nitrogen-containing chelating ligands on the structures of zinc(II) 4,4'-ethylenedibenzoates.
    Wang XY; Wang JJ; Ng SW
    Acta Crystallogr C; 2008 Dec; 64(Pt 12):m401-4. PubMed ID: 19057070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel vanadium(V) compounds with a layer structure: synthesis, crystal structures, and solid state NMR spectroscopy of [(VO(2))(2)(4,4'-bpy)(0.5)(4,4'-Hbpy)(XO(4))] x H(2)O (X = P and As).
    Huang LH; Kao HM; Lii KH
    Inorg Chem; 2002 Jun; 41(11):2936-40. PubMed ID: 12033902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Speciation of potential anti-diabetic vanadium complexes in real serum samples.
    Sanna D; Ugone V; Serra M; Garribba E
    J Inorg Biochem; 2017 Aug; 173():52-65. PubMed ID: 28499214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.